Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDActual EPS
CollPlant Biotechnologies Ltd. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 1 | -$0.04 | -$0.04 | -$0.04 |
| Q2 2025 | 1 | -$0.03 | -$0.03 | -$0.03 |
| Q3 2025 | 1 | -$0.02 | -$0.02 | -$0.02 |
| Q4 2025 | 1 | -$0.02 | -$0.02 | -$0.02 |
| Q1 2026 | 0 | $0.00 | $0.00 | $0.00 |
| Q2 2026 | 0 | $0.00 | $0.00 | $0.00 |
| Q3 2026 | 0 | $0.00 | $0.00 | $0.00 |
| Q4 2026 | 0 | $0.00 | $0.00 | $0.00 |
| Q1 2027 | 0 | $0.00 | $0.00 | $0.00 |
| Q2 2027 | 0 | $0.00 | $0.00 | $0.00 |
| Q3 2027 | 0 | $0.00 | $0.00 | $0.00 |
| Q4 2027 | 0 | $0.00 | $0.00 | $0.00 |
| Q1 2028 | 0 | $0.00 | $0.00 | $0.00 |
| Q2 2028 | 0 | $0.00 | $0.00 | $0.00 |
| Q3 2028 | 0 | $0.00 | $0.00 | $0.00 |
| Q4 2028 | 0 | $0.00 | $0.00 | $0.00 |
CollPlant Biotechnologies Ltd. Earnings Date And Information
CollPlant Biotechnologies Ltd. last posted its earnings results on Wednesday, March 26th, 2025. The company reported $-0.34 earnings per share for the quarter, topping analysts' consensus estimates of $-0.42 by $0.08. The company had revenue of 164,000 for the quarter and had revenue of 515,000 for the year. CollPlant Biotechnologies Ltd. has generated $-1 earnings per share over the last year ($-1.45 diluted earnings per share) and currently has a price-to-earnings ratio of -1.38. CollPlant Biotechnologies Ltd. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 27th, 2025 based on prior year's report dates.
CollPlant Biotechnologies Ltd. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 03/26/2025 | Q4 2024 | -$0.42 | -$0.34 | 0.08 | $100,000 | $164,000 |
| 11/27/2024 | Q3 2024 | -$0.28 | -$0.38 | -0.1 | $416,000 | $4,000 |
| 08/20/2024 | Q2 2024 | -$0.35 | -$0.37 | -0.02 | $395,500 | $249,000 |
| 04/04/2024 | Q1 2024 | -$0.35 | -$0.37 | -0.02 | $642,000 | $98,000 |
| 04/04/2024 | Q4 2023 | -$0.35 | -$0.41 | -0.06 | $8.56 M | $299,000 |
| 11/29/2023 | Q3 2023 | -$0.13 | -$0.38 | -0.25 | $3.50 M | $43,000 |
| 05/24/2023 | Q2 2023 | -$0.29 | $0.51 | 0.8 | $3.59 M | $10.18 M |
| 03/29/2023 | Q1 2023 | -$0.21 | -$0.35 | -0.14 | $238,333 | $433,000 |
| 03/29/2023 | Q4 2022 | -$0.21 | -$0.37 | -0.16 | $100,000 | $58,000 |
| 12/01/2022 | Q3 2022 | -$0.31 | -$0.39 | -0.08 | $3.10 M | $109,000 |
| 05/26/2022 | Q2 2022 | -$0.14 | -$0.40 | -0.26 | $2.86 M | $66,000 |
| 03/24/2022 | Q1 2022 | -$0.26 | -$0.37 | -0.11 | $2.74 M | $66,000 |
| 12/31/2021 | Q4 2021 | N/A | -$0.35 | N/A | $338,000 | $310,000 |
| 11/18/2021 | Q3 2021 | -$0.28 | -$0.29 | -0.01 | $246,000 | $140,000 |
| 05/27/2021 | Q2 2021 | $0.51 | -$0.30 | -0.81 | $3.10 M | $691,000 |
| 03/26/2021 | Q1 2021 | -$0.30 | $1.20 | 1.5 | $10.06 M | $14.50 M |
| 12/31/2020 | Q4 2020 | N/A | -$0.42 | N/A | $569,000 | $557,000 |
| 12/01/2020 | Q3 2020 | $0.92 | $0.10 | -0.82 | N/A | $4.15 M |
| 06/30/2020 | Q2 2020 | N/A | -$0.28 | N/A | $1.54 M | $823,000 |
| 04/01/2020 | Q1 2020 | -$0.13 | -$0.24 | -0.11 | $691,500 | $609,000 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
CollPlant Biotechnologies Ltd. Earnings: FAQ's
CollPlant Biotechnologies Ltd. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 27th, 2025 based offlast year's report dates.
In the previous quarter, CollPlant Biotechnologies Ltd. (:CLGN) reported $-0.34 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.42 by $0.08.
The conference call for CollPlant Biotechnologies Ltd.'s latest earnings report can be listened to online.
The conference call transcript for CollPlant Biotechnologies Ltd.'s latest earnings report can be read online.
CollPlant Biotechnologies Ltd. (:CLGN) has a recorded annual revenue of $515,000.
CollPlant Biotechnologies Ltd. (:CLGN) has a recorded net income of $-16,609,000.CollPlant Biotechnologies Ltd. has generated $-1.45 earnings per share over the last four quarters.
CollPlant Biotechnologies Ltd. (:CLGN) has a price-to-earnings ratio of -1.38 and price/earnings-to-growth ratio is -0.3.